Teladoc Health (TDOC) Common Equity (2013 - 2026)

Teladoc Health has disclosed Common Equity across 14 years of filings, most recently posting $1.3 billion for Q1 2026.

• Common Equity for Q1 2026 came in at $1.3 billion, down 6.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (down 6.36% YoY), and the FY2025 annual result was $1.4 billion, down 7.07% from the prior year.
• Common Equity came in at $1.3 billion for Q1 2026 at Teladoc Health, down from $1.4 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $9.1 billion in Q1 2022 to a low of $1.3 billion in Q1 2026.
• The 5-year median for Common Equity is $2.3 billion (2024), against an average of $2.7 billion.
• Across the five-year window, Common Equity sank 85.62% in 2022 and gained 0.79% in 2023, its largest moves.
• Teladoc Health's Common Equity stood at $2.3 billion in 2022, then increased by 0.79% to $2.3 billion in 2023, then plunged by 35.9% to $1.5 billion in 2024, then declined by 7.07% to $1.4 billion in 2025, then fell by 3.56% to $1.3 billion in 2026.
• The last three Common Equity figures came in at $1.3 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.